World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
80
Citations
25659
World Ranking
4037
National Ranking
27

Peter F. Ambros publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Peter F. Ambros sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 308 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Peter F. Ambros D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Peter F. Ambros sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 80 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Peter F. Ambros is affiliated with St Anna Children's Hospital in Austria. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in the subfields of Neurology, Cancer Research, Molecular Biology, Genetics, and Oncology.

Their recent publication record includes studies focused on pediatric cancers and neuroblastoma. Notable papers are:

  • Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden, 2021, Nature Communications
  • Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1), 2020, Cancers
  • Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study, 2020, Journal of Clinical Oncology
  • Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome, 2021, Nature Communications
  • Schwann cell plasticity regulates neuroblastic tumor cell differentiation via epidermal growth factor-like protein 8, 2021, Nature Communications

Frequent collaborators include:

  • Inge M. Ambros
  • Sabine Taschner-Mandl
  • Ruth Ladenstein
  • Fikret Rifatbegovic
  • Marie Bernkopf

Prominent publication venues for their work are:

  • Journal of Clinical Oncology
  • Nature Communications
  • Cancers
  • Zenodo (CERN European Organization for Nuclear Research)
  • Cancer Research

Their primary research topics encompass:

  • Neuroblastoma Research and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Cancer therapeutics and mechanisms
  • Neuroendocrine Tumor Research Advances
  • Virus-based gene therapy research
  • Glioma Diagnosis and Treatment
  • Lung Cancer Research Studies

This profile reflects a career engaged deeply in pediatric oncology research, with particular emphasis on neuroblastoma biology and treatment. The scientist has contributed to advancing molecular understanding and clinical approaches in their areas of study.

Best Publications

  • The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

    Susan L. Cohn;Andrew D.J. Pearson;Wendy B. London;Tom Monclair

  • Truncating Mutations of hSNF5/INI1 in Aggressive Paediatric Cancer

    Isabella Versteege;Nicolas Sévenet;Julian Lange;Marie-Françoise Rousseau-Merck

  • The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

    Tom Monclair;Garrett M. Brodeur;Peter F. Ambros;Hervé J. Brisse

  • MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration.

    Inge M. Ambros;Peter F. Ambros;Sabine Strehl;Heinrich Kovar

  • Advances in Risk Classification and Treatment Strategies for Neuroblastoma

    Navin R. Pinto;Mark A. Applebaum;Samuel L. Volchenboum;Katherine K. Matthay

  • Classification of isolated tumor cells and micrometastasis.

    Gabor Mehes;Armin Witt;Ernst Kubista;Peter F. Ambros

  • International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

    PF Ambros;IM Ambros;GM Brodeur;M Haber

  • Chromosomally integrated human herpesvirus 6: questions and answers

    Philip E. Pellett;Dharam V. Ablashi;Peter F. Ambros;Henri Agut

  • The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro

    Jesse H. Arbuckle;Maria M. Medveczky;Janos Luka;Stephen H. Hadley

  • Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

    Ruth Ladenstein;Ruth Ladenstein;Ulrike Pötschger;Andrew D J Pearson;Penelope Brock

  • Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

    Ruth Ladenstein;Ulrike Pötschger;Dominique Valteau-Couanet;Roberto Luksch

  • hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics.

    Matthias Wieser;Guido Stadler;Paul Jennings;Berthold Streubel

  • Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

    Wendy B. London;Victoria Castel;Tom Monclair;Peter F. Ambros

  • Modification of DAPI banding on human chromosomes by prestaining with a DNA-binding oligopeptide antibiotic, distamycin A.

    D. Schweizer;P. Ambros;M. Andrle

  • Circulating Breast Cancer Cells Are Frequently Apoptotic

    Gábor Méhes;Armin Witt;Ernst Kubista;Peter F. Ambros

  • A novel putative tyrosine kinase receptor with oncogenic potential.

    J. W. G. Janssen;A. S. Schulz;A. C. M. Steenvoorden;M. Schmidberger

  • Application of Giemsa banding to orchid karyotype analysis

    Trude Schwarzacher;Peter Ambros;Dieter Schweizer

  • Gene amplification as double minutes or homogeneously staining regions in solid tumors: Origin and structure

    Clelia Tiziana Storlazzi;Angelo Lonoce;Maria C. Guastadisegni;Domenico Trombetta

  • DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma

    Nathan C. Sheffield;Gaelle Pierron;Johanna Klughammer;Paul Datlinger

  • Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor.

    H Kovar;M Dworzak;S Strehl;E Schnell

Frequent Co-Authors

Helmut Gadner
Helmut Gadner St Anna Children's Hospital
Heinrich Kovar
Heinrich Kovar St Anna Children's Hospital
Wendy B. London
Wendy B. London Harvard University
Andrew D.J. Pearson
Andrew D.J. Pearson Royal Marsden NHS Foundation Trust
Susan L. Cohn
Susan L. Cohn University of Chicago
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Genevieve Laureys
Genevieve Laureys Ghent University Hospital
Olivier Delattre
Olivier Delattre PSL University
Tommy Martinsson
Tommy Martinsson University of Gothenburg
Thomas Lion
Thomas Lion Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry opens doors to a wide range of health and science careers. For students interested in imaging or diagnostics, there are online radiology tech programs that offer a flexible and affordable path into healthcare technology fields.

Nutrition-focused students may want to consider the best dietetics programs. These degrees can help you become a registered dietitian or nutrition expert, blending biochemistry with real-world client care.

There are also growing opportunities in patient care and administration. Fast-track your entry into healthcare by considering online medical assisting classes—many of which offer financial aid to help you get started faster.

For certified medical assistants looking to expand their qualifications, the cma to lpn bridge program online offers a streamlined progression to becoming a Licensed Practical Nurse, allowing for greater responsibility and salary potential.

Each pathway brings unique challenges and benefits, but all can help launch a rewarding science-based career in the ever-evolving field of healthcare.

Best Scientists Citing Peter F. Ambros

Trending Scientists

Recently Published Articles